Authors
Latest:
Interactive Case Studies: September 2023Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.
Latest:
Pharmacogenomics Offers a Glimpse Into the Future of PharmacyOne day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.
Latest:
Staff Pharmacists Discuss Updated Carboplatin Drug Shortage Mitigation Strategies at the University of Illinois at Chicago Oncology Clinic PharmacyAfter carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Latest:
Clinical Overview: Mavacamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Latest:
Therapies in the Pipeline for Prostate CancerNew potential medications may continue to expand the role of targeted agents.
Latest:
Tip of the Week: We Are All Clinician-ManagersThe evolution of health care to a more patient-centric focus suggests an even greater marriage between the concepts of manager and clinician.
Latest:
Microbiology Quality Control Helps the Cell and Gene Therapy Segment Cure the IncurableWith the continued advancement and approval of cell and gene therapies, the need for trustworthy microbiology quality control solutions is at an all-time high.
Latest:
Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene TherapiesAlthough payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”
Latest:
Once-Daily Oral Pill for Plaque Psoriasis Shows PromiseDeuvacracitinib (Sotyktu), which the FDA approved in September 2022, is a first-of-its-class tyrosine kinase 2 inhibitor and a member of the Janus kinase family.
Latest:
Case Study: Review of ACE Inhibitor-Induced Bowel AngioedemaGlobally, more than 40 million patients are currently taking an ACE inhibitor, primarily for the treatment of high blood pressure and heart failure.
Latest:
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ DiseaseAchieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest:
Cancer Vaccine Trials With Canines May Benefit Cancer Prevention in HumansThe clinical trial success in canines may have broader implications for applicability.
Latest:
Experiences With Racial and Ethnic Minority Patients Give Students Lessons Beyond the ClassroomPharmacists can leverage their own identities to advocate for happier, healthier individuals within communities of different ethnic and socioeconomic backgrounds
Latest:
Mental Health Awareness is Vital Year-RoundAs pharmacy professionals battle with their own challenges regarding mental health, the optimal role of psychiatric pharmacists is yet to be defined.
Latest:
Variation in Psoriasis Treatment Regimens Come at a CostDue to the disease’s chronicity, the variability in treatment response and drug safety profiles, and the availability of multiple therapies, switching or discontinuing treatments is common in psoriasis.
Latest:
Addressing Mental Health Disparities in Black WomenPharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.
Latest:
Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple MyelomaIntegration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Latest:
Pharmacists Should Play Key Role in PharmacogenomicsFind nontraditional financing streams, identify optimal learning materials to dive into this growing space.
Latest:
Handling Hazardous Drugs Presents OpportunitiesA compliance officer role represents an exciting new challenge to ensure safe handling in compliance with United States Pharmacopeia.
Latest:
The Integration of Empathy Is Essential to the Success of Digital Health Care TechnologyHealth care is inherently human, so digital health care technology aimed at advancing human health needs empathy to be successful.
Latest:
Clinical Overview: Skysona for Early Cerebral AdrenoleukodystrophyCerebral adrenoleukodystrophy is a progressive neurodegenerative disease causes irreversible neurologic decline and can result in functional disabilities, such hearing loss and cortical blindness.
Latest:
Fauci Warns About BQ.1 and BQ.1.1 COVID-19 Variants – What to Know and How to Stay SafeNew COVID-19 variants are always cause for concern but are not a cause for panic.
Latest:
Impact of the Inflation Reduction Act on Vaccinations: What Pharmacists Need to KnowBy educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.
Latest:
What Pharmacists Should Know About Drug DiversionDuring a recent roundtable discussion, industry leaders shared frontline insights on the biggest drug diversion challenges.
Latest:
Gridlock, Middleman Lobbying Cause Pharmacy Benefit Manager Reforms to Fail Again in New York BudgetMany pharmacies and safety-net providers were preparing for the long-anticipated transition from Medicaid managed care to fee-for-service (FFS)—known as the carve-out—that was set to take effect on May 1, 2021.
Latest:
Equal but Not the Same—2021 Update on Influenza VaccinesAs COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.
Latest:
February Marks American Heart MonthPharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.
Latest:
Clinical Overview: Exploring the Impact of Co-Crystal Celecoxib and Tramadol CombinationCombining tramadol and celecoxib into a co-crystal of celecoxib-tramadol provides peripherally and centrally mediated analgesia.
